ArticleAnnals of hematology2025

A complete response with daratumumab, venetoclax, azacitidine and dexamethasone in a heavily pre-treated, chemo-refractory early T-precursor acute lymphoblastic leukemia/lymphoma patient.

Süreyya Yiğit Kaya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.